Back
ProShares UltraPro Short MidCap400 Vs. Kymera Therapeutics Industry Stock Comparison
Sell
1
SMDD
ProShares UltraPro Short MidCap400
Last Price:
8.51
Seasonality Move:
-19.43%
Buy
71
KYMR
Kymera Therapeutics
Last Price:
48.99
Seasonality Move:
65.72%
Sell
1
ProShares UltraPro Short MidCap400 (SMDD)
is a Sell
Is ProShares UltraPro Short MidCap400 a Buy, Sell or Hold?
- The current ProShares UltraPro Short MidCap400 [SMDD] share price is $8.55. The Score for SMDD is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- SMDD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SMDD Stock Price Chart
What is ProShares UltraPro Short MidCap400's stock price today?
-
The ProShares UltraPro Short MidCap400 share price today is $8.55
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMDD is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $49.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMDD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 33.34 | Sell |
| Chaikin Money Flow: | -1204 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.91 - 9.77) | Sell |
| Bollinger Bands (100): | (9.52 - 11.38) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 59.12 | Buy |
| Chaikin Money Flow: | 317205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.81 - 49.49) | Buy |
| Bollinger Bands (100): | (34.86 - 47.92) | Buy |
SMDD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.01 | Sell |
| 20-day SMA: | 9.17 | Sell |
| 50-day SMA: | 9.9 | Sell |
| 200-day SMA: | 11.31 | Sell |
| 8-day EMA: | 8.92 | Sell |
| 20-day EMA: | 9.23 | Sell |
| 50-day EMA: | 9.74 | Sell |
| 200-day EMA: | 11.77 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.58 | Buy |
| 20-day SMA: | 46.67 | Buy |
| 50-day SMA: | 46.11 | Buy |
| 200-day SMA: | 38.62 | Buy |
| 8-day EMA: | 45.67 | Buy |
| 20-day EMA: | 45.85 | Buy |
| 50-day EMA: | 45.2 | Buy |
| 200-day EMA: | 38.5 | Buy |
ProShares UltraPro Short MidCap400 Earnings Growth & SMDD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
ProShares UltraPro Short MidCap400 Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||